Skip to content

Shattuck Labs, Inc. STTK Business Segments — Loss from operations

Similar metrics at other companies

Archer Aviation logo
ACHRReportable Segment — Loss from operations
-$254.6M-76.8%
Lexicon Pharmaceuticals logo
LXRXReportable Segment — Loss from operations
-$996K+96.1%
Replimune Group logo
REPLReportable Segment — Operating Income (Loss)
-$71.87M-8.9%
Immunovant, Inc. logo
IMVTReportable Segment — Net loss
$147.86M+38.9%
Sionna Therapeutics, Inc. Common Stock logo
SIONReportable Segment — Net loss
-$26.78M-62.5%
Mirum Pharmaceuticals, Inc. logo
MIRMReportable Segment — Operating Income (Loss)
-$789.47M-5,100%

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s business segments — loss from operations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s business segments — loss from operations?
Shattuck Labs, Inc. (STTK) reported business segments — loss from operations of -$15.55M in Q1 2026.
How has Shattuck Labs, Inc.'s business segments — loss from operations changed year-over-year?
Shattuck Labs, Inc.'s business segments — loss from operations decreased by 8.0% year-over-year, from -$14.39M to -$15.55M.
What is the long-term trend for Shattuck Labs, Inc.'s business segments — loss from operations?
Over 2 years (2023 to 2025), Shattuck Labs, Inc.'s business segments — loss from operations has grown at a -25.2% compound annual growth rate (CAGR), from -$91.96M to -$51.51M.
What does business segments — loss from operations mean?
Calculated as the difference between segment revenue and total operating expenses, representing the net financial shortfall from core activities. For clinical-stage companies, this metric highlights the extent to which operating costs exceed revenue as the company invests in product development.